Catalyst Wire Dossier Catalyst Wire Dossier

Trivalent Virosomal Influenza Vaccine (2012-2013 formulation)

trivalent virosomal influenza vaccine · Adimmune Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Trivalent Virosomal Influenza Vaccine (2012-2013 formulation), covering 2018-07-16 to 2018-07-16. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects [Phase 3]

See pricing